Show simple item record

dc.contributor.authorKurane, Ichiro
dc.contributor.authorZeng, Lingling
dc.contributor.authorBrinton, Margo A.
dc.contributor.authorEnnis, Francis A.
dc.date2022-08-11T08:09:09.000
dc.date.accessioned2022-08-23T16:19:36Z
dc.date.available2022-08-23T16:19:36Z
dc.date.issued1998-01-20
dc.date.submitted2017-10-02
dc.identifier.citationVirology. 1998 Jan 15;240(2):169-74. <a href="https://doi.org/10.1006/viro.1997.8925">Link to article on publisher's site</a>
dc.identifier.issn0042-6822 (Linking)
dc.identifier.doi10.1006/viro.1997.8925
dc.identifier.pmid9454689
dc.identifier.urihttp://hdl.handle.net/20.500.14038/35088
dc.description.abstractThe role of dengue virus-specific serotype-cross-reactive T lymphocytes in recovery from and pathogenesis of dengue virus infections is not known. In the present paper, we have defined a dengue serotype-cross-reactive epitope recognized by two CD4+ CD8- cytotoxic T lymphocyte (CTL) clones, JK36 and JK46. These T cell clones were established from the peripheral blood T lymphocytes of a dengue-3-immune donor, using a limiting dilution method. JK36 and JK46 were cross-reactive for dengue virus types 2, 3, and 4, but not for type 1, and recognized the NS3 protein. The smallest synthetic peptide recognized by JK36 was an 8-amino acid peptide that contains amino acids (aa) 226 to 233 (VVAAEMEE) of NS3. The smallest peptide recognized by JK46 was an 11-amino acid peptide that contains aa 224 to 234 (TRVVAAEMEEA). HLA-DR15 was the restriction allele for recognition of these peptides by both JK36 and JK46. This is the first epitope to be defined that is recognized by human CD4+ CTL cross-reactive for dengue virus types 2, 3, and 4.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=9454689&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1006/viro.1997.8925
dc.subjectImmunity
dc.subjectImmunology and Infectious Disease
dc.subjectImmunology of Infectious Disease
dc.subjectInfectious Disease
dc.subjectVirology
dc.titleDefinition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4
dc.typeJournal Article
dc.source.journaltitleVirology
dc.source.volume240
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/infdis_pp/299
dc.identifier.contextkey10843615
html.description.abstract<p>The role of dengue virus-specific serotype-cross-reactive T lymphocytes in recovery from and pathogenesis of dengue virus infections is not known. In the present paper, we have defined a dengue serotype-cross-reactive epitope recognized by two CD4+ CD8- cytotoxic T lymphocyte (CTL) clones, JK36 and JK46. These T cell clones were established from the peripheral blood T lymphocytes of a dengue-3-immune donor, using a limiting dilution method. JK36 and JK46 were cross-reactive for dengue virus types 2, 3, and 4, but not for type 1, and recognized the NS3 protein. The smallest synthetic peptide recognized by JK36 was an 8-amino acid peptide that contains amino acids (aa) 226 to 233 (VVAAEMEE) of NS3. The smallest peptide recognized by JK46 was an 11-amino acid peptide that contains aa 224 to 234 (TRVVAAEMEEA). HLA-DR15 was the restriction allele for recognition of these peptides by both JK36 and JK46. This is the first epitope to be defined that is recognized by human CD4+ CTL cross-reactive for dengue virus types 2, 3, and 4.</p>
dc.identifier.submissionpathinfdis_pp/299
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.contributor.departmentCenter for Infectious Disease and Vaccine Research
dc.source.pages169-74


This item appears in the following Collection(s)

Show simple item record